Sionna Therapeutics (SION) Share-based Compensation (2024 - 2026)

Sionna Therapeutics (SION) has 3 years of Share-based Compensation data on file, last reported at $6.6 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 212.94% year-over-year to $6.6 million; the trailing twelve-month figure through Mar 2026 stood at $16.5 million (up 220.56% YoY), and the FY2025 full-year result was $12.1 million, up 225.4% from the prior year.
• Share-based Compensation improved to $6.6 million in Q1 2026, from $3.8 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $6.6 million in Q1 2026 to a low of $647000.0 in Q1 2024.
• A 3-year average of $2.5 million and a median of $2.1 million in 2025 frame the typical range for Share-based Compensation.
• Peak annual rise in Share-based Compensation reached 259.59% in 2025, while the deepest fall reached 192.48% in 2025.
• Tracing SION's Share-based Compensation over 3 years: stood at $1.1 million in 2024, then jumped by 259.59% to $3.8 million in 2025, then jumped by 71.28% to $6.6 million in 2026.
• Business Quant data shows SION's Share-based Compensation at $6.6 million in Q1 2026, $3.8 million in Q4 2025, and $3.3 million in Q3 2025.